Literature DB >> 17075146

Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease, France, 2006.

B Coignard1, F Barbut, K Blanckaert, J M Thiolet, I Poujol, A Carbonne, J C Petit, J C Desenclos.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17075146     DOI： 10.2807/esw.11.37.03044-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


× No keyword cloud information.
  14 in total

1.  Clostridium difficile O27 colitis: hospital-onset but community-acquired.

Authors:  S Buffet-Bataillon; P Tattevin; H Sénéchal; M Cormier; P Vincent
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09       Impact factor: 3.267

2.  Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.

Authors:  Michelle Merrigan; Anilrudh Venugopal; Michael Mallozzi; Bryan Roxas; V K Viswanathan; Stuart Johnson; Dale N Gerding; Gayatri Vedantam
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

3.  Underestimation of Clostridium difficile infection among clinicians: an international survey.

Authors:  M N Mavros; V G Alexiou; K Z Vardakas; K Tsokali; T A Sardi; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-27       Impact factor: 3.267

4.  Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.

Authors:  Susan M Novak-Weekley; Elizabeth M Marlowe; John M Miller; Joven Cumpio; Jim H Nomura; Paula H Vance; Alice Weissfeld
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

5.  Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens.

Authors:  Danielle Wroblewski; George E Hannett; Dianna J Bopp; Ghinwa K Dumyati; Tanya A Halse; Nellie B Dumas; Kimberlee A Musser
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

6.  Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in France.

Authors:  Katy Jeannot; Laure Diancourt; Sophie Vaux; Michelle Thouverez; Amandina Ribeiro; Bruno Coignard; Patrice Courvalin; Sylvain Brisse
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

7.  Epidemiology of Clostridioides difficile infections, France, 2010 to 2017.

Authors:  Mélanie Colomb-Cotinat; Laetitia Assouvie; Julien Durand; Côme Daniau; Lucie Leon; Sylvie Maugat; Sophan Soing-Altrach; Cécile Gateau; Jeanne Couturier; Isabelle Arnaud; Pascal Astagneau; Anne Berger-Carbonne; Frédéric Barbut
Journal:  Euro Surveill       Date:  2019-08

8.  [Emerging multidrug-resistant microorganisms among travelers returning to France and persons repatriated from foreign hospitals].

Authors:  Didier Lepelletier; Antoine Andremont; Patrick Choutet
Journal:  Bull Acad Natl Med       Date:  2009-11       Impact factor: 0.144

Review 9.  Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread.

Authors:  Archie C A Clements; Ricardo J Soares Magalhães; Andrew J Tatem; David L Paterson; Thomas V Riley
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

10.  Clostridium difficile infection in a French university hospital: Eight years of prospective surveillance study.

Authors:  Nagham Khanafer; Luc Oltra; Monique Hulin; Olivier Dauwalder; Francois Vandenesch; Philippe Vanhems
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.